中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

非酒精性脂肪性肝病患者肺功能变化临床分析

陈志惠 张世荣 孙文静 文良志 刘凯军 郭严 魏艳玲 王斌 顾小红 陈东风

引用本文:
Citation:

非酒精性脂肪性肝病患者肺功能变化临床分析

DOI: 10.3969/j.issn.1001-5256.2018.04.026
详细信息
  • 中图分类号: R575.5

A clinical study of pulmonary function changes in patients with nonalcoholic fatty liver disease

  • 摘要:

    目的分析探讨非酒精性脂肪性肝病(NAFLD)患者肺功能的变化及意义。方法选取2016年9月-2017年5月于陆军军医大学大坪医院体检中心进行体检的非酒精性脂肪性肝病(NAFLD)患者为NAFLD组(n=275),非NAFLD患者为对照组(n=276),对2组人群的肺功能资料进行分析,包括用力肺活量(FVC)、1秒钟用力呼气容积(FEV1)及FEV1/FVC比值,同时对ALT升高的NAFLD组和ALT正常的NAFLD组的肺功能指标进行比较。计量资料方差齐者2组间比较采用两独立样本t检验,方差不齐则采用非参数Wilcoxon秩和检验。计数资料2组间比较采用χ2检验。结果 NAFLD组FVC、FEV1分别为(3.60±0.87)L、(2.97±0.79)L,均低于对照组的(3.87±0.80)L、(3.17±0.81)L,差异均有统计学意义(t值分别为-3.78、-2.87,P值均<0.01)。nafld组fev1 p="">0.05)。ALT升高的NAFLD组FVC、FEV1、FEV...

     

  • [1]TAPPER EB, LOOMBA R.NAFLD, Metabolic syndrome, and the fight that will define clinical practice for a generation of hepatologists[J].Hepatology, 2017.[Epub ahead of print]
    [2]TARGHER G, BYRNE CD, LONARDO A, et al.Non-alcoholic fatty liver disease and risk of incident cardiovascular disease:a meta-analysis[J].J Hepatol, 2016, 65 (3) :589-600.
    [3]FAN JG, KIM SU, WONG VW.New trends on obesity and NAFLD in Asia[J].J Hepatol, 2017, 67 (4) :862-873.
    [4]BYRNE CD, TARGHER G.NAFLD:a multisystem disease[J].J Hepatol, 2015, 62 (Suppl 1) :s47-s64.
    [5]SINN DH, KANG D, CHANG Y, et al.Non-alcoholic fatty liver disease and progression of coronary artery calcium score:a retrospective cohort study[J].Gut, 2017, 66 (2) :323-329.
    [6]TARGHER G, CHONCHOL M, ZOPPINI G, et al.Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease:is there a link?[J].J Hepatol, 2011, 54 (5) :1020-1029.
    [7]ZOPPINI G, FEDELI U, GENNARO N, et al.Mortality from chronic liver diseases in diabetes[J].Am J Gastroenterol, 2014, 109 (7) :1020-1025.
    [8]Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.
    [9]LIU YF, XIE W.Progress in treatment of nonalcoholic fatty liver disease[J/CD].Chin J Liver Dis:Electronic Edititon, 2016, 8 (1) :26-28. (in Chinese) 刘玉凤, 谢雯.非酒精性脂肪性肝病治疗进展[J/CD].中国肝脏病杂志:电子版, 2016, 8 (1) :26-28.
    [10]LIU Y, YANG LQ.Analysis of the prevalence of nonalcoholic fatty liver disease and its related diseases among faculties in a certain university in Beijing[J].China Med Herald, 2017, 32 (14) :178-181. (in Chinese) 刘英, 杨立强.北京某高校教职工非酒精性脂肪性肝病的患病率及相关疾病分析[J].中国医药导报, 2017, 32 (14) :178-181.
    [11]YOUNG RP, HOPKINS RJ, MARSLAND B.The Gut-liver-lung axis.modulation of the innate immune response and its possible role in chronic obstructive pulmonary disease[J].Am J Respir Cell Mol Biol, 2016, 54 (2) :161-169.
    [12]du PLESSIS J, van PELT J, KORF H, et al.Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease[J].Gastroenterology, 2015, 149 (3) :635-648.
    [13]MEKOV E, SLAVOVA Y, TSAKOVA A, et al.Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease[J].Peer J, 2015, 3:e1068.
    [14]XU C, WAN X, XU L, et al.Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia:one stone hits two birds[J].J Hepatol, 2015, 62 (6) :1412-1419.
    [15]HIRSOVA P, IBRAHIM SH, KRISHNAN A, et al.Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes[J].Gastroenterology, 2016, 150 (4) :956-967.
    [16]BARB D, PORTILLO-SANCHEZ P, CUSI K.Pharmacological management of nonalcoholic fatty liver disease[J].Metabolism, 2016, 65 (8) :1183-1195.
    [17]BAFFI CW, WOOD L, WINNICA D, et al.Metabolic syndrome and the lung[J].Chest, 2016, 149 (6) :1525-1534.
    [18]PENG TC, KAO TW, WU LW, et al.Association between pulmonary function and nonalcoholic fatty liver disease in the NHANES III study[J].Medicine (Baltimore) , 2015, 94 (21) :e907.
    [19]KIM SK, BAE JC, BAEK JH, et al.Decline in lung function rather than baseline lung function is associated with the development of metabolic syndrome:a six-year longitudinal study[J].PLo S One, 2017, 12 (3) :e174228.
    [20]DA SP, de MELLO MT, CHEIK NC, et al.Interdisciplinary therapy improves biomarkers profile and lung function in asthmatic obese adolescents[J].Pediatr Pulmonol, 2012, 47 (1) :8-17.
    [21]JUNG DH, SHIM JY, LEE HR, et al.Relationship between nonalcoholic fatty liver disease and pulmonary function[J].Intern Med J, 2012, 42 (5) :541-546.
  • 加载中
计量
  • 文章访问数:  1499
  • HTML全文浏览量:  15
  • PDF下载量:  364
  • 被引次数: 0
出版历程
  • 出版日期:  2018-04-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回